The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Noxxon Pharma Appoints Jarl Ulf Jungnelius as CMO (2017-02-10)
FOCUS ON ONCOLOGY CLINICAL DEVELOPMENT ALLOWS RECRUITMENT OF SPECIALIST INVOLVED IN APPROVAL OF MULTIPLE ONCOLOGY AGENTS NOXXON Pharma N.V. (Alternext Paris: ALNOX), a biotechnology company whose core focus is on cancer treatment, has today announced that Jarl...
- Novo A/S Invests €90.3m in Evotec, for 8.9% Shareholding (2017-02-09)
- Novo A/S invests EUR 90.3 m in new Evotec shares resulting in ownership of approx. 8.9% after the capital increase - New long-term shareholding to strengthen Evotec's strategic business case in the drug discovery outsourcing industry Evotec AG (Frankfurt ...
- Cevec Licenses CAP Technologies to NewLink Genetics (2017-02-09)
Agreement marks an important step in establishing CAP® technologies as the new global industrial standard for viral vector and vaccine development CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gen...
- AMRI, Bruker and HighRes to Advance Mass Spec for HTS (2017-02-07)
AMRI (NASDAQ: AMRI), a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass...
- Global Bioenergies: First Production of Fully Renewable ETBE (2017-02-07)
In a historic first, Global Bioenergies today announces the production of ETBE purely from renewable resources. The breakthrough heralds a new opportunity for increasing the proportion of biofuels in gasoline. Current standards limit the inclusion of traditional...
- Forbion Invests in Prexton Therapeutics’ €29m Series B Round (2017-02-07)
Forbion & Seroba co-led funding, forming international consortium with Merck Ventures, Ysios and Sunstone Funding to finance two Phase II trials in Parkinson’s disease Forbion Capital Partners (“Forbion”), one of the leading Dutch Venture Capital firms inve...
- Pieris Pharmaceuticals CFO Darlene Deptula-Hicks Resigns (2017-02-07)
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform, today announced that Darlene Deptula-Hicks has submitted her resignation, effective today, to...
- Genedata Announces New Screener Ready-to-Run Partners (2017-02-06)
New partners join the turnkey integration program with Genedata Screener enabling researchers to quickly import and analyze raw data from innovative screening instruments Genedata, a leading provider of advanced software solutions for drug discovery and life s...
- Analytik Jena: uHTS MALDI Sample Preparation for Bruker MS (2017-02-06)
Analytik Jena has joined forces with Bruker Daltonics to accelerate lab processes: uHTS MALDI Sample Preparation in combination with label-free spectrometry guarantees reliable ultra high throughput screens in biopharmaceutical labs. The process will premiere at th...
- Lipotype Is Partner in New IMI Project BEAt-DKD (2017-02-06)
BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Ju...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)